Brief: Nova Eye Medical Reports Record FY25 Revenue Of A$29.2 MLN
29/07/2025 02:33
July 29 (Reuters) - Nova Eye Medical Ltd EYE.AX: REPORTS RECORD FY25 REVENUE OF A$29.2 MILLION TARGETS BREAKEVEN EBITDA IN H1FY26 FY26 SALES REVENUE (EXCLUDING CHINA) FORECAST BETWEEN US$21 MILLION TO US$24 MILLION Further company coverage: EYE.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nova Eye Medical
See all newsAustralia's Nova Eye Medical jumps on upbeat FY27 earnings guidance
Brief: Nova Eye Medical Reports FY26 Sales Of $23.7 Million
Australia's Nova Eye Medical soars on FY26 sales forecast upgrade
Brief: Nova Eye Medical Upgrades Fy26 Sales Guidance (Ex-China) To $22–23 Million
Australia's Nova Eye Medical rises on EU approval for glaucoma treatment